Thomas Storme

755 total citations
31 papers, 546 citations indexed

About

Thomas Storme is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Oncology. According to data from OpenAlex, Thomas Storme has authored 31 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pediatrics, Perinatology and Child Health, 8 papers in Pharmacology and 6 papers in Oncology. Recurrent topics in Thomas Storme's work include Pharmaceutical studies and practices (13 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Effects and risks of endocrine disrupting chemicals (5 papers). Thomas Storme is often cited by papers focused on Pharmaceutical studies and practices (13 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Effects and risks of endocrine disrupting chemicals (5 papers). Thomas Storme collaborates with scholars based in France, United Kingdom and Estonia. Thomas Storme's co-authors include Évelyne Jacqz-Aigrain, Wei Zhao, May Fakhoury, André Baruchel, M. Turner, Daolun Zhang, Anne Maisin, Georges Deschênes, Mony Fahd and André Rieutord and has published in prestigious journals such as SHILAP Revista de lepidopterología, Advanced Drug Delivery Reviews and Scientific Reports.

In The Last Decade

Thomas Storme

30 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Storme France 13 232 196 122 91 84 31 546
Yi Zheng China 14 161 0.7× 271 1.4× 91 0.7× 48 0.5× 154 1.8× 65 630
Silvia Romano‐Moreno Mexico 15 106 0.5× 214 1.1× 154 1.3× 66 0.7× 96 1.1× 47 528
Susanna Edith Medellín‐Garibay Mexico 15 81 0.3× 180 0.9× 151 1.2× 59 0.6× 83 1.0× 44 541
María Victoria Martínez Calvo Spain 14 80 0.3× 299 1.5× 147 1.2× 72 0.8× 144 1.7× 44 620
Raül Rigo‐Bonnin Spain 14 85 0.4× 261 1.3× 101 0.8× 63 0.7× 149 1.8× 78 741
Michel Lavit France 14 55 0.2× 186 0.9× 95 0.8× 179 2.0× 133 1.6× 36 643
Kersti Oselin Estonia 15 237 1.0× 175 0.9× 114 0.9× 373 4.1× 102 1.2× 41 721
Mariadelfina Molinaro Italy 13 82 0.4× 102 0.5× 187 1.5× 65 0.7× 123 1.5× 26 505
A M Taburet France 19 236 1.0× 93 0.5× 239 2.0× 129 1.4× 150 1.8× 31 709
M. Van Guilder United States 8 97 0.4× 309 1.6× 106 0.9× 44 0.5× 251 3.0× 12 571

Countries citing papers authored by Thomas Storme

Since Specialization
Citations

This map shows the geographic impact of Thomas Storme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Storme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Storme more than expected).

Fields of papers citing papers by Thomas Storme

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Storme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Storme. The network helps show where Thomas Storme may publish in the future.

Co-authorship network of co-authors of Thomas Storme

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Storme. A scholar is included among the top collaborators of Thomas Storme based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Storme. Thomas Storme is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lagarce, Frédéric, Isabelle Roland, Denis Brossard, et al.. (2024). Recommendations on training objectives and staff qualification for the manual preparation of capsules in pharmacy. SHILAP Revista de lepidopterología. 9(1). 1 indexed citations
2.
Fillaudeau, Luc, et al.. (2024). A comparative study of gellan gum and xanthan gum versus commercial vehicles as pharmaceutical thickening agents in oral suspensions. European Journal of Pharmaceutics and Biopharmaceutics. 207. 114622–114622. 1 indexed citations
3.
Hobson, Claire Amaris, Mélanie Magnan, Benoît Chassaing, et al.. (2022). A Microbiota-Dependent Response to Anticancer Treatment in an In Vitro Human Microbiota Model: A Pilot Study With Hydroxycarbamide and Daunorubicin. Frontiers in Cellular and Infection Microbiology. 12. 886447–886447. 2 indexed citations
5.
Pansiot, Julien, Marina Colella, Thomas Storme, et al.. (2020). In-line filtration in very preterm neonates: a randomized controlled trial. Scientific Reports. 10(1). 5003–5003. 6 indexed citations
6.
Hobson, Claire Amaris, Stéphane Bonacorsi, Didier Hocquet, et al.. (2020). Impact of anticancer chemotherapy on the extension of beta-lactamase spectrum: an example with KPC-type carbapenemase activity towards ceftazidime-avibactam. Scientific Reports. 10(1). 589–589. 22 indexed citations
7.
Élie, Valery, Sophie Magréault, Anne Maisin, et al.. (2019). Population Pharmacokinetics of Ganciclovir after Valganciclovir Treatment in Children with Renal Transplant. Antimicrobial Agents and Chemotherapy. 63(12). 18 indexed citations
8.
Leroux, Stéphanie, Thomas Storme, Daolun Zhang, et al.. (2019). Body Surface Area-Based Dosing Regimen of Caspofungin in Children: a Population Pharmacokinetics Confirmatory Study. Antimicrobial Agents and Chemotherapy. 63(7). 10 indexed citations
9.
Magréault, Sophie, et al.. (2019). UPLC/MS/MS assay for the simultaneous determination of seven antibiotics in human serum–Application to pediatric studies. Journal of Pharmaceutical and Biomedical Analysis. 174. 256–262. 23 indexed citations
10.
Metsvaht, Tuuli, Heili Varendi, Anthony J Nunn, et al.. (2015). High variability in the dosing of commonly used antibiotics revealed by a Europe-wide point prevalence study: implications for research and dissemination. BMC Pediatrics. 15(1). 41–41. 65 indexed citations
11.
Delezoide, Anne‐Lise, Wei Zhao, Fabien Guimiot, et al.. (2015). Safety study of Ciprofloxacin in newborn mice. Regulatory Toxicology and Pharmacology. 74. 161–169. 14 indexed citations
12.
Turner, M., Jennifer C Duncan, Urvashi Shah, et al.. (2013). European Study of Neonatal Exposure to Excipients: An update. International Journal of Pharmaceutics. 457(1). 357–358. 18 indexed citations
13.
Turner, M., Jennifer C Duncan, Urvashi Shah, et al.. (2013). Risk assessment of neonatal excipient exposure: Lessons from food safety and other areas. Advanced Drug Delivery Reviews. 73. 89–101. 36 indexed citations
14.
Walter, E., et al.. (2012). Cost analysis of neonatal and pediatric parenteral nutrition in Europe: a multi-country study. European Journal of Clinical Nutrition. 66(5). 639–644. 17 indexed citations
15.
Zhao, Wei, Anne Maisin, Véronique Baudouin, et al.. (2012). Limited sampling strategy using Bayesian estimation for estimating individual exposure of the once-daily prolonged-release formulation of tacrolimus in kidney transplant children. European Journal of Clinical Pharmacology. 69(5). 1181–1185. 9 indexed citations
16.
Zhao, Wei, May Fakhoury, Véronique Baudouin, et al.. (2012). Population pharmacokinetics and pharmacogenetics of once daily prolonged-release formulation of tacrolimus in pediatric and adolescent kidney transplant recipients. European Journal of Clinical Pharmacology. 69(2). 189–195. 51 indexed citations
17.
Zhao, Wei, May Fakhoury, Anne Maisin, et al.. (2012). Pharmacogenetic Determinant of the Drug Interaction Between Tacrolimus and Omeprazole. Therapeutic Drug Monitoring. 34(6). 739–741. 12 indexed citations
18.
Tang, Ruoping, Anne‐Marie Faussat, Jean‐Yves Perrot, et al.. (2008). Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia (AML). BMC Cancer. 8(1). 51–51. 52 indexed citations
19.
Storme, Thomas, Alain Deroussent, Élise Prost, et al.. (2008). New Ifosfamide Analogs Designed for Lower Associated Neurotoxicity and Nephrotoxicity with Modified Alkylating Kinetics Leading to Enhanced in Vitro Anticancer Activity. Journal of Pharmacology and Experimental Therapeutics. 328(2). 598–609. 9 indexed citations
20.
Bouligand, Jérôme, Thomas Storme, O. Oberlin, et al.. (2005). Quality control and stability study using HPTLC: applications to cyclophosphamide in various pharmaceutical products. Journal of Pharmaceutical and Biomedical Analysis. 38(1). 180–185. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026